Novel medicament for treating cognitive impairment

Details Novel medicament for treating cognitive impairment Novel medicament for treating cognitive impairment

C - Chemistry, Metallurgy

07

D

C07D 207/333 (2006.01) A61K 31/40 (2006.01) A61P 1/16 (2006.01) A61P 3/08 (2006.01) A61P 5/14 (2006.01) A61P 5/18 (2006.01) A61P 9/00 (2006.01) A61P 9/04 (2006.01) A61P 9/10 (2006.01) A61P 13/12 (2006.01) A61P 19/08 (2006.01) A61P 21/04 (2006.01) A61P 25/00 (2006.01) A61P 25/08 (2006.01) A61P 25/28 (2006.01) A61P 25/32 (2006.01) A61P 31/04 (2006.01) A61P 35/00 (2006.01) A61P 43/00 (2006.01)

Patent

CA 2754416

The present invention provides a medicament for preventing and/or treating cognitive impairment, in particular Alzheimer's dementia, comprising 2-methyl-2-[(4--{(1E)-3-[2-(4-methylbenzoyl)-1H-pyrrol-1-yl]prop-1-en-1-- yl}benzyl)oxy]propionic acid or a pharmaceutically acceptable salt or solvate thereof.

Cette invention concerne un agent prophylactique et/ou thérapeutique pour le déficit cognitif dont la démence du type Alzheimer, qui comprend un acide 2-méthyl-2-[(4-{(1E)-3-[2-(4-méthylbenzoyl)-1H-pyrrol-1-yl]prop-1-én-1- yl}benzyl)oxy]propionique, un sel pharmaceutiquement acceptable dudit composé, ou un solvate du composé ou du sel.

Affiliated with

Also associated with

Rating

Novel medicament for treating cognitive impairment does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel medicament for treating cognitive impairment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel medicament for treating cognitive impairment will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1504459